E-cigarette Ban in Brazil: Ignorance and Health Risks

Aug.16.2024
E-cigarette Ban in Brazil: Ignorance and Health Risks
Brazil e-cigarette devices banned due to Anvisa decision, with many citizens unaware of the regulation, according to Folhape study.

According to a recent research report released by the Brazilian media Folhape, e-cigarette devices have been banned in Brazil due to a decision by the National Health Surveillance Agency (Anvisa). However, the study found that many Brazilian citizens are still unclear about the regulations surrounding this issue.


A report has shown that 87.2% of respondents are aware of what e-cigarettes are, but only 54.9% know that they are illegal products. Additionally, 44.6% of people believe that e-cigarettes are fashionable, while 20.7% think using them is relaxing. At the same time, 60% of respondents believe that smoking e-cigarettes is harmful to health.


Among the respondents, 74.6% said they have never used any type of e-cigarette, while 19.4% said they have used at least once. Among the group who have tried e-cigarettes before, 2.8% said they use them regularly.


Regarding safety, 90.3% of respondents are aware that e-cigarettes may be related to the occurrence of cancer, 94.8% of respondents know that they contain toxic substances, and 94.3% of respondents believe that e-cigarettes may increase the risk of chronic diseases.


However, 74.5% of respondents believe that it is acceptable to use e-cigarettes in bars and restaurants with outdoor areas, with 16.6% of people also thinking that it is permissible to use e-cigarettes in enclosed spaces.


The main reason why e-cigarettes are banned in Brazil is because they contain nicotine, which can lead to dependency. According to research from the Clinical Hospital of the University of Sao Paulo in Brazil, traditional cigarettes contain 1mg of nicotine, while e-cigarettes can contain up to 57mg per milliliter. Additionally, the Brazilian Medical Association (AMB) points out that one e-cigarette is equivalent to 20 traditional cigarettes.


Experts also point out that e-cigarettes contain up to 2000 substances, most of which are of unknown origin. The colorful packaging and fruity flavors are believed to be very attractive to teenagers, who are the main consumers of e-cigarettes.


A study by University College London (UCL) and the University of Innsbruck in Austria found that e-cigarettes may damage DNA, potentially leading to cancer. As a result, Brazil's National Health Surveillance Agency (Anvisa) has banned the production, distribution, storage, and transportation of e-cigarettes. This measure reinforces regulations put in place since 2009 that prohibit the import, sale, and promotion of e-cigarettes.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Seoul to Fine Use of Liquid E-Cigarettes in No-Smoking Areas From April 24
Seoul to Fine Use of Liquid E-Cigarettes in No-Smoking Areas From April 24
Seoul will begin fining the use of all tobacco products, including liquid e-cigarettes, in no-smoking areas from April 24, when the revised Tobacco Business Act takes effect.
Apr.09 by 2FIRSTS.ai
EVO NXT 2026 Opens in Prague as Global NGP Industry Gathers for Two-Day Event
EVO NXT 2026 Opens in Prague as Global NGP Industry Gathers for Two-Day Event
2026 — EVO NXT 2026 officially opened today in Prague, bringing together manufacturers, brand owners, retailers, and decision-makers from across the global next-generation products (NGP) industry. As the event’s official media partner for the fourth consecutive year, 2Firsts is reporting on site, tracking key developments across the exhibition floor, forum agenda, and broader industry discussions.
Apr.17 by 2FIRSTS.ai
Special Report|Reynolds’ 337 Patent Case Ends, but a Harsher 337 Compliance Battle Now Targets the Entire Vape Supply Chain
Special Report|Reynolds’ 337 Patent Case Ends, but a Harsher 337 Compliance Battle Now Targets the Entire Vape Supply Chain
The U.S. International Trade Commission (ITC) has terminated Investigation 337-TA-1410 after invalidating key vape patent claims asserted by R.J. Reynolds Vapor Company, removing the immediate risk of import bans for dozens of companies. However, a new case—337-TA-1486—has already opened a more consequential legal front, shifting the focus from patent disputes to regulatory compliance across the vape supply chain, including PACT Act reporting, tax compliance, and FDA marketing authorization.
BAT
Mar.11
China Tobacco International (HK) Announces FY2025 Results: Revenue Reaches HK$14.58 Billion, Up 11.5% Year-on-Year
China Tobacco International (HK) Announces FY2025 Results: Revenue Reaches HK$14.58 Billion, Up 11.5% Year-on-Year
China Tobacco International (HK) Company Limited announced its audited results for the year ended December 31, 2025. Revenue was HK$14.58 billion, profit before taxation was HK$1.28 billion, and profit attributable to owners of the Company was HK$0.98 billion, with basic and diluted EPS of HK$1.42. The Board proposed a final dividend of HK$0.33 per share; together with an interim dividend of HK$0.19 per share, the full-year dividend totaled HK$0.52 per share.
Mar.06 by 2FIRSTS.ai
West Virginia Governor Signs Bill Directing USD 2.9 Million From Juul Settlement to Youth Tobacco Prevention
West Virginia Governor Signs Bill Directing USD 2.9 Million From Juul Settlement to Youth Tobacco Prevention
The American Cancer Society Cancer Action Network said West Virginia Governor Patrick Morrisey has signed House Bill 5691 into law, directing USD 2.9 million from the Juul settlement to youth tobacco prevention and programs that help people quit. The bill is a supplemental appropriation measure, and the Legislature’s bill history shows it passed the House on March 11, passed the Senate on March 13 and was sent to the governor on March 18.
Mar.20 by 2FIRSTS.ai
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas says newly released internal FDA records show agency scientific reviewers supported authorization for several flavored G2 products before senior leadership halted them. According to documents obtained through a Freedom of Information Act request, FDA’s Office of Science first recommended marketing authorization for all eight products in December 2025 and later supported six of them in February 2026. FDA ultimately authorized only the G2 device and one tobacco-flavored pod in March.
Apr.23 by 2FIRSTS.ai